KRAS and atrial fibrillation: Patients with plasma mutant KRAS levels above 75% had a disease control rate of 0%, whereas those with lower levels had a rate of 42% (p = 0.048), indicating that ctDNA KRAS mutation AF predicts disease behavior (117).